{"nctId":"NCT00364182","briefTitle":"Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B","startDateStruct":{"date":"2007-05"},"conditions":["Hemophilia B"],"count":50,"armGroups":[{"label":"A","type":"EXPERIMENTAL","interventionNames":["Drug: Recombinant Coagulation Factor IX (BeneFIX)"]},{"label":"B","type":"EXPERIMENTAL","interventionNames":["Drug: Recombinant Coagulation Factor IX (BeneFIX)"]}],"interventions":[{"name":"Recombinant Coagulation Factor IX (BeneFIX)","otherNames":[]},{"name":"Recombinant Coagulation Factor IX (BeneFIX)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Documented history of moderately severe or severe hemophilia B (FIX:C less than or equal to 2%)\n* Male subjects, aged 6 years to 65 years.\n* Subjects with a minimum of 12 bleeding episodes, 6 of which must be joint bleeds, in the 12 months before screening.\n\nExclusion Criteria:\n\n* Subjects currently utilizing FIX primary prophylaxis.\n* Subjects with HIV+ who have a CD4 count less than 200\n* Subjects with hepatic or renal impairment.\n* Prothrombin time or International Normalized Ration more than 1.5 times the upper limit of normal.\n* Major surgery or an orthopedic surgical procedure within the past 3 months or is planned within the duration of participation in this study.\n* Past history of, or current FIX inhibitor.\n* Hypersensitivity to any FIX product or hamster protein.\n* Exposure to any investigational drug, except for rFIX-R, or device within 30 days of providing consent/assent (as appropriate) for this study.\n* Bleeding disorders other than hemophilia B.\n* Concurrent inflammatory disease that in the investigator's judgment could confound the study results.","healthyVolunteers":false,"sex":"MALE","minimumAge":"6 Years","maximumAge":"65 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Annualized Number of Bleeding Episodes","description":"Annualized bleed rate (ABR) or number of bleeds per year derived for each participant for each treatment regimen by using the following formula: ABR = number of bleeds / (days on treatment regimen / 365.25)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.1","spread":null},{"groupId":"OG001","value":"4.6","spread":null},{"groupId":"OG002","value":"2.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Amount of Sleep Measured by Sleep Diary After Hemarthrosis","description":"For each bleeding event, a diary was filled out that night and the subsequent night. Questions included: How long do you think you slept last night? Reported as average duration of sleep during study.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"2.0"},{"groupId":"OG001","value":"7.3","spread":"1.8"},{"groupId":"OG002","value":"7.1","spread":"1.6"},{"groupId":"OG003","value":"7.4","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.9","spread":"1.7"},{"groupId":"OG001","value":"7.8","spread":"1.6"},{"groupId":"OG002","value":"7.5","spread":"1.4"},{"groupId":"OG003","value":"8.0","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Quality of Sleep Measured by Sleep Diary After Hemarthrosis","description":"For each bleeding event, a diary was filled out that night and the subsequent night. Questions included: How would you describe the quality of your sleep last night? 1=Very Good, 2=Good, 3=Fair, 4=Poor, 5=Very Poor. Reported as quality of sleep during study.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"0.9"},{"groupId":"OG001","value":"2.5","spread":"0.9"},{"groupId":"OG002","value":"2.3","spread":"0.9"},{"groupId":"OG003","value":"2.4","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"0.7"},{"groupId":"OG001","value":"2.1","spread":"0.8"},{"groupId":"OG002","value":"2.1","spread":"0.7"},{"groupId":"OG003","value":"2.1","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Acute Pain After Hemarthrosis","description":"For each bleeding event, a diary was filled out that night and the subsequent night and included a Brief Pain Inventory (BPI): self-reported scale that measured severity of pain experienced over the past 24 hours. Questions included How much pain right now? 0 (no pain) to 10 (pain as severe as you can imagine).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"2.1"},{"groupId":"OG001","value":"2.8","spread":"2.0"},{"groupId":"OG002","value":"3.1","spread":"2.2"},{"groupId":"OG003","value":"3.0","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"1.6"},{"groupId":"OG001","value":"1.8","spread":"1.2"},{"groupId":"OG002","value":"2.7","spread":"1.5"},{"groupId":"OG003","value":"4.1","spread":"2.4"}]}]}]},{"type":"SECONDARY","title":"Health-Related Productivity Questionnaire (HRPQ) Score: Hours Lost From Work or School at 24 Hours Post-bleed","description":"HRPQ: self-reported scale that measured for each bleed event, hours lost from work, school and housework because of hemophilia and its treatments. Mean and standard deviations calculated from measured values.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"1.6"},{"groupId":"OG001","value":"1.2","spread":"2.6"},{"groupId":"OG002","value":"0.6","spread":"1.9"},{"groupId":"OG003","value":"0.6","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"2.4"},{"groupId":"OG001","value":"0.3","spread":"0.8"},{"groupId":"OG002","value":"0.4","spread":"0.7"},{"groupId":"OG003","value":"0.2","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.7"},{"groupId":"OG001","value":"0.7","spread":"2.2"},{"groupId":"OG002","value":"0.4","spread":"1.1"},{"groupId":"OG003","value":"0.0","spread":"0.0"}]}]}]},{"type":"SECONDARY","title":"HRPQ Score: Hours Lost From Work or School at 48 Hours Post-bleed","description":"HRPQ: self-reported scale that measured for each bleed event, hours lost from work, school and housework because of hemophilia and its treatments. Mean and standard deviations calculated from measured values.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"1.0"},{"groupId":"OG001","value":"0.7","spread":"2.1"},{"groupId":"OG002","value":"0.1","spread":"0.4"},{"groupId":"OG003","value":"0.2","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"1.4"},{"groupId":"OG001","value":"0.3","spread":"0.7"},{"groupId":"OG002","value":"0.0","spread":"0.2"},{"groupId":"OG003","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"1.2"},{"groupId":"OG001","value":"0.7","spread":"2.4"},{"groupId":"OG002","value":"0.0","spread":"0.0"},{"groupId":"OG003","value":"1.7","spread":"2.6"}]}]}]},{"type":"SECONDARY","title":"36-Item Short-Form Health Survey (SF-36): Physical Functioning Domain","description":"SF-36: standardized survey evaluating 8 aspects of functional health and well being: physical and social functioning, physical and emotional role limitations, bodily pain, general health, vitality, and mental health. The physical functioning domain score was an average of the individual physical functioning question scores across all time points, which was scaled 0-100 (100=highest level of functioning).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":"26"},{"groupId":"OG001","value":"66","spread":"25"},{"groupId":"OG002","value":"63","spread":"28"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":50},"commonTop":["Headache","Arthralgia"]}}}